194 related articles for article (PubMed ID: 12860900)
1. Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae-induced cell interaction and activation.
Dechend R; Gieffers J; Dietz R; Joerres A; Rupp J; Luft FC; Maass M
Circulation; 2003 Jul; 108(3):261-5. PubMed ID: 12860900
[TBL] [Abstract][Full Text] [Related]
2. HMG-CoA reductase inhibition reduces the proinflammatory activation of human vascular smooth muscle cells by the terminal complement factor C5b-9.
Viedt C; Shen W; Fei J; Kamimura M; Hänsch GM; Katus HA; Kreuzer J
Basic Res Cardiol; 2003 Nov; 98(6):353-61. PubMed ID: 14556080
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway.
Li J; Li JJ; He JG; Nan JL; Guo YL; Xiong CM
Cardiovasc Ther; 2010; 28(1):8-14. PubMed ID: 20074254
[TBL] [Abstract][Full Text] [Related]
4. HMG-CoA reductase inhibitors up-regulate anti-aging klotho mRNA via RhoA inactivation in IMCD3 cells.
Narumiya H; Sasaki S; Kuwahara N; Irie H; Kusaba T; Kameyama H; Tamagaki K; Hatta T; Takeda K; Matsubara H
Cardiovasc Res; 2004 Nov; 64(2):331-6. PubMed ID: 15485693
[TBL] [Abstract][Full Text] [Related]
5. HMG-CoA reductase inhibitors reduce nicotine-induced expression of cellular adhesion molecules in cultured human coronary endothelial cells.
Cirillo P; Pacileo M; De Rosa S; Calabrò P; Gargiulo A; Angri V; Prevete N; Fiorentino I; Ucci G; Sasso L; Petrillo G; Musto D'Amore S; Chiariello M
J Vasc Res; 2007; 44(6):460-70. PubMed ID: 17657162
[TBL] [Abstract][Full Text] [Related]
6. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes.
Blanco-Colio LM; Muñoz-García B; Martín-Ventura JL; Lorz C; Díaz C; Hernández G; Egido J
Circulation; 2003 Sep; 108(12):1506-13. PubMed ID: 12952848
[TBL] [Abstract][Full Text] [Related]
7. Statins inhibit in vitro calcification of human vascular smooth muscle cells induced by inflammatory mediators.
Kizu A; Shioi A; Jono S; Koyama H; Okuno Y; Nishizawa Y
J Cell Biochem; 2004 Nov; 93(5):1011-9. PubMed ID: 15389884
[TBL] [Abstract][Full Text] [Related]
8. Withdrawal of cerivastatin induces monocyte chemoattractant protein 1 and tissue factor expression in cultured vascular smooth muscle cells.
Brandes RP; Beer S; Ha T; Busse R
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1794-800. PubMed ID: 12933532
[TBL] [Abstract][Full Text] [Related]
9. Chlamydia pneumoniae activates nuclear factor kappaB and activator protein 1 in human vascular smooth muscle and induces cellular proliferation.
Miller SA; Selzman CH; Shames BD; Barton HA; Johnson SM; Harken AH
J Surg Res; 2000 May; 90(1):76-81. PubMed ID: 10781378
[TBL] [Abstract][Full Text] [Related]
10. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells.
Wei CY; Huang KC; Chou YH; Hsieh PF; Lin KH; Lin WW
Mol Pharmacol; 2006 Mar; 69(3):960-7. PubMed ID: 16317111
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 2 mediates persistent chemokine release by Chlamydia pneumoniae-infected vascular smooth muscle cells.
Yang X; Coriolan D; Schultz K; Golenbock DT; Beasley D
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2308-14. PubMed ID: 16179594
[TBL] [Abstract][Full Text] [Related]
12. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
[TBL] [Abstract][Full Text] [Related]
13. Statins activate GATA-6 and induce differentiated vascular smooth muscle cells.
Wada H; Abe M; Ono K; Morimoto T; Kawamura T; Takaya T; Satoh N; Fujita M; Kita T; Shimatsu A; Hasegawa K
Biochem Biophys Res Commun; 2008 Oct; 374(4):731-6. PubMed ID: 18671946
[TBL] [Abstract][Full Text] [Related]
14. Rac1 regulation of surface expression of protease-activated receptor-1 and responsiveness to thrombin in vascular smooth muscle cells.
Yufu T; Hirano K; Bi D; Hirano M; Nishimura J; Iwamoto Y; Kanaide H
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1506-11. PubMed ID: 15860737
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory stress induces statin resistance by disrupting 3-hydroxy-3-methylglutaryl-CoA reductase feedback regulation.
Chen Y; Ku H; Zhao L; Wheeler DC; Li LC; Li Q; Varghese Z; Moorhead JF; Powis SH; Huang A; Ruan XZ
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):365-76. PubMed ID: 24233489
[TBL] [Abstract][Full Text] [Related]
16. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
[TBL] [Abstract][Full Text] [Related]
17. RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation.
Fromigué O; Haÿ E; Modrowski D; Bouvet S; Jacquel A; Auberger P; Marie PJ
Cell Death Differ; 2006 Nov; 13(11):1845-56. PubMed ID: 16470222
[TBL] [Abstract][Full Text] [Related]
18. RhoA-mediated, tumor necrosis factor alpha-induced activation of NF-kappaB in rheumatoid synoviocytes: inhibitory effect of simvastatin.
Xu H; Liu P; Liang L; Danesh FR; Yang X; Ye Y; Zhan Z; Yu X; Peng H; Sun L
Arthritis Rheum; 2006 Nov; 54(11):3441-51. PubMed ID: 17075836
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of cyclooxygenase-2 by motorcycle exhaust particulate-induced reactive oxygen species enhances rat vascular smooth muscle cell proliferation.
Tzeng HP; Yang RS; Ueng TH; Liu SH
Chem Res Toxicol; 2007 Aug; 20(8):1170-6. PubMed ID: 17645304
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins.
Haendeler J; Hoffmann J; Zeiher AM; Dimmeler S
Circulation; 2004 Aug; 110(7):856-61. PubMed ID: 15289372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
